Literature DB >> 7997475

Principle of the bark of Phellodendron amurense to suppress the cellular immune response.

H Mori1, M Fuchigami, N Inoue, H Nagai, A Koda, I Nishioka.   

Abstract

We previously reported that Wen-Qing-Yin (Unsei-in), a traditional Chinese blended medicine, inhibited the induction phase of various kinds of delayed type hypersensitivity (DTH) and local graft-versus-host (GvH) reactions, but did not affect humoral immune responses or the effector phase of DTH in experimental animals. In another report, we demonstrated that Phellodendri Cortex (bark of Phellodendron amurense Rupr. Rutaceae) was a component having the most potent suppressive effect on the cellular immune response among the 8 medical plants composing Unsei-in. In the present study, we isolated OB-1 and OB-5 from Phellodendri Cortex as the biologically active principles to suppress local GvH reactions in mice. OB-1 and OB-5 are quaternary base alkaloids known as magnoflorine and phellodendrine, respectively. They suppressed the local GvH reaction, when given i.p. to the host mice at 5-20 mg/kg for 8 consecutive days from the day of spleen cell transfer to cause the reaction. Both OB-1 and OB-5 suppressed picryl chloride-induced delayed type hypersensitivity (PC-DTH) when given i.p. to mice at 10 and 20 mg/kg for 5 consecutive days from the day of the sensitization, but did not suppress it when given at the time of the challenge. These results suggest that OB-1 and OB-5 suppress the induction phase but not the effector phase of the cellular immune response. They are expected to have a value as a new type of immunosuppressor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7997475     DOI: 10.1055/s-2006-959529

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  8 in total

1.  Extraction, characterization and bioactive properties of Nigella sativa seedcake.

Authors:  Deepak Kadam; S S Lele
Journal:  J Food Sci Technol       Date:  2017-09-11       Impact factor: 2.701

2.  Possible inhibitor from traditional Chinese medicine for the β form of calcium-dependent protein kinase type II in the treatment of major depressive disorder.

Authors:  Tzu-Chieh Hung; Wen-Yuan Lee; Kuen-Bao Chen; Hung-Jin Huang; Yueh-Chiu Chan; Cheng-Chun Lee; Calvin Yu-Chian Chen
Journal:  Biomed Res Int       Date:  2014-06-18       Impact factor: 3.411

3.  Traditional Chinese Medicine Use among Patients with Psoriasis in Taiwan: A Nationwide Population-Based Study.

Authors:  Shu-Wen Weng; Bor-Chyuan Chen; Yu-Chiao Wang; Chun-Kai Liu; Mao-Feng Sun; Ching-Mao Chang; Jaung-Geng Lin; Hung-Rong Yen
Journal:  Evid Based Complement Alternat Med       Date:  2016-10-16       Impact factor: 2.629

4.  Phytochemical Quantification and the In Vitro Acetylcholinesterase Inhibitory Activity of Phellodendron chinense and Its Components.

Authors:  Yu Jin Kim; Hye-Sun Lim; Yoonju Kim; Jun Lee; Bu-Yeo Kim; Soo-Jin Jeong
Journal:  Molecules       Date:  2017-06-02       Impact factor: 4.411

5.  Utilizing network pharmacology and experimental validation to investigate the underlying mechanism of phellodendrine on inflammation.

Authors:  Lili Hu; Jue Wang; Na Wu; Xiaoge Zhao; Donghui Cai
Journal:  PeerJ       Date:  2022-09-23       Impact factor: 3.061

6.  An Alternative Approach to Atopic Dermatitis: Part I-Case-Series Presentation.

Authors:  Hiromi Kobayashi; Kuniaki Takahashi; Nobuyuki Mizuno; Haruo Kutsuna; Masamitsu Ishii
Journal:  Evid Based Complement Alternat Med       Date:  2004-06-01       Impact factor: 2.629

7.  The inhibition of folylpolyglutamate synthetase (folC) in the prevention of drug resistance in Mycobacterium tuberculosis by traditional Chinese medicine.

Authors:  Tzu-Chieh Hung; Kuen-Bao Chen; Wen-Yuan Lee; Calvin Yu-Chian Chen
Journal:  Biomed Res Int       Date:  2014-06-19       Impact factor: 3.411

Review 8.  Phellodendri Cortex: A Phytochemical, Pharmacological, and Pharmacokinetic Review.

Authors:  Yue Sun; George Binh Lenon; Angela Wei Hong Yang
Journal:  Evid Based Complement Alternat Med       Date:  2019-04-01       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.